WALKER NEAL (President and CEO) exercised options at ACLARIS THERAPEUTICS, INC.
Option exercise — a mechanical event triggered by vesting or expiry. Not a discretionary conviction trade.
M · 1 exercise
Filed: 2/5/2026ACC: 0001604457-26-000005
DirectorOfficer· President and CEO
Since Dec 2018
-18.61K
Net shares
Net seller
$64.6K
Total sold
0
Open market trades
0B · 0S
3
Total transactions
63.48K acquired · 82.09K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+63.48K
Price / share
—
Trade value
—
% of position
4.2%
2/3/2026
1.50M→1.56M
Common Stock
Direct
Shares
−18.61K
Price / share
$3.47
Trade value
$64.58K
% of position
1.2%
2/3/2026
1.56M→1.54M
Total
Net shares
+44.86K
Net value
-$64.58K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/3/2026 | M · Option Exercise | +63.48K | — | — | 4.2% | 1.50M | 1.56M |
| Common Stock Direct | 2/3/2026 | F · Tax Withholding | −18.61K | $3.47 | $64.58K | 1.2% | 1.56M | 1.54M |
| Total | +44.86K | -$64.58K | ||||||
Derivative Transactions1
Restricted Stock Units
Direct
Converts to
Common Stock
63.48K shares
Shares
−63.48K
Strike price
Held after
190.43K
Exercisable
—
2/3/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Units Direct | Common Stock63.48K shares | 2/3/2026 | M · Option Exercise | −63.48K | — | 190.43K |